RIPK3 and neoplasm: Surprisingly, in the majority of cancers, both RIPK3 and MLKL promoted tumor immune cell infiltration, particularly in BUC where MLKL increased the infiltration of neutrophils, which supports previous findings that necroptosis can boost antitumor immunity [34].